LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.59 | 21.74 | 1136 | 4492 | 0.2529 | 0.6726 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.59 | 21.74 | 155 | 4492 | 0.0345 | 0.2910 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 47.59 | 21.74 | 1156 | 4492 | 0.2573 | 0.6764 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.56 | 21.74 | 1139 | 4838 | 0.2354 | 0.6614 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.56 | 21.74 | 1167 | 4838 | 0.2412 | 0.6666 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.56 | 21.74 | 172 | 4838 | 0.0355 | 0.3037 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 49.56 | 21.74 | 1193 | 4838 | 0.2466 | 0.6713 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.53 | 21.74 | 1170 | 5150 | 0.2272 | 0.6574 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.53 | 21.74 | 1191 | 5150 | 0.2312 | 0.6612 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.53 | 21.74 | 192 | 5150 | 0.0373 | 0.3181 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 51.53 | 21.74 | 1226 | 5150 | 0.2380 | 0.6673 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.50 | 21.74 | 1219 | 5425 | 0.2247 | 0.6581 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.50 | 21.74 | 1239 | 5425 | 0.2284 | 0.6615 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.50 | 21.74 | 195 | 5425 | 0.0359 | 0.3172 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 53.50 | 21.74 | 1243 | 5425 | 0.2291 | 0.6621 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 21.74 | 1223 | 5768 | 0.2120 | 0.6496 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 21.74 | 1244 | 5768 | 0.2156 | 0.6530 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 21.74 | 226 | 5768 | 0.0392 | 0.3375 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 55.48 | 21.74 | 1297 | 5768 | 0.2248 | 0.6616 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.45 | 21.74 | 1302 | 6023 | 0.2162 | 0.6559 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.45 | 21.74 | 1322 | 6023 | 0.2195 | 0.6591 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.45 | 21.74 | 225 | 6023 | 0.0374 | 0.3338 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 57.45 | 21.74 | 1296 | 6023 | 0.2152 | 0.6550 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 59.42 | 21.74 | 1267 | 6125 | 0.2069 | 0.6479 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 59.42 | 21.74 | 1287 | 6125 | 0.2101 | 0.6511 | MN20160310_N01 | D08 |